Back to GetFilings.com



Table of Contents

 


 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For The Quarterly Period Ended March 31, 2003

 

or

 

¨    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD

FROM________ TO_________             

 

Commission File Number 001-15811

 


 

MARKEL CORPORATION

(Exact name of registrant as specified in its charter)

 

Virginia

 

54-1959284

(State or other jurisdiction of

 

(I.R.S. employer

incorporation or organization)

 

identification number)

 

4521 Highwoods Parkway, Glen Allen, Virginia 23060-6148

(Address of principal executive offices)

(Zip code)

 

(804) 747-0136

(Registrant’s telephone number, including area code)

 

NONE

(Former name, former address and former fiscal year,

if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES    x    No    ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    YES    x    No    ¨

 

Number of shares of the registrant’s common stock outstanding at May 2, 2003: 9,840,428

 


 


Table of Contents

 

Markel Corporation

Form 10-Q

 

Index

 

PART I. FINANCIAL INFORMATION

  

Page Number

Item 1. Financial Statements

    

Consolidated Balance Sheets—
March 31, 2003 and December 31, 2002

  

3

Consolidated Statements of Operations and Comprehensive Income —
Three Months Ended March 31, 2003 and 2002

  

4

Consolidated Statements of Changes in Shareholders’ Equity —
Three Months Ended March 31, 2003 and 2002

  

5

Consolidated Statements of Cash Flows—
Three Months Ended March 31, 2003 and 2002

  

6

Notes to Consolidated Financial Statements—
March 31, 2003

  

7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of
Operations

  

14

Critical Accounting Policies

  

14

Item 3. Quantitative and Qualitative Disclosures About Market Risk

  

21

Item 4. Controls and Procedures

  

21

Safe Harbor and Cautionary Statement

  

22

PART II. OTHER INFORMATION

    

Item 6. Exhibits and Reports on Form 8-K

  

23

Signatures

  

24

Section 302 Certification of the Chief Executive Officer

  

25

Section 302 Certification of the Chief Financial Officer

  

26

Exhibit Index

  

27

 

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Balance Sheets

 

 

 

    

March 31, 2003

    

December 31,

2002

 

    

(dollars in thousands)

 

ASSETS

                 

Investments, available-for-sale, at estimated fair value

                 

Fixed maturities (cost of $3,389,274 in 2003 and $3,119,814 in 2002)

  

$

3,515,158

 

  

$

3,251,186

 

Equity securities (cost of $443,926 in 2003 and $406,635 in 2002)

  

 

563,327

 

  

 

550,909

 

Short-term investments (estimated fair value approximates cost)

  

 

93,353

 

  

 

67,821

 


Total Investments, Available-For-Sale

  

 

4,171,838

 

  

 

3,869,916

 


Cash and cash equivalents

  

 

245,776

 

  

 

444,236

 

Receivables

  

 

437,211

 

  

 

408,542

 

Reinsurance recoverable on unpaid losses

  

 

1,519,687

 

  

 

1,586,128

 

Reinsurance recoverable on paid losses

  

 

127,339

 

  

 

144,751

 

Deferred policy acquisition costs

  

 

161,126

 

  

 

150,547

 

Prepaid reinsurance premiums

  

 

233,420

 

  

 

219,665

 

Intangible assets

  

 

358,815

 

  

 

361,444

 

Other assets

  

 

249,596

 

  

 

223,331

 


Total Assets

  

$

7,504,808

 

  

$

7,408,560

 


LIABILITIES AND SHAREHOLDERS’ EQUITY

                 

Unpaid losses and loss adjustment expenses

  

$

4,387,646

 

  

$

4,366,803

 

Unearned premiums

  

 

992,468

 

  

 

937,364

 

Payables to insurance companies

  

 

130,686

 

  

 

122,191

 

Convertible notes payable (estimated fair value of $94,000 in 2003 and $89,000 in 2002)

  

 

87,218

 

  

 

86,109

 

Long-term debt (estimated fair value of $447,000 in 2003 and $415,000 in 2002)

  

 

427,831

 

  

 

404,384

 

Other liabilities

  

 

150,962

 

  

 

182,598

 

Company-Obligated Mandatorily Redeemable Preferred Capital Securities of Subsidiary

                 

Trust Holding Solely Junior Subordinated Deferrable Interest Debentures of Markel Corporation (estimated fair value of $128,000 in 2003 and $118,000 in 2002)

  

 

150,000

 

  

 

150,000

 


Total Liabilities

  

 

6,326,811

 

  

 

6,249,449

 


Shareholders’ equity

                 

Common stock

  

 

736,451

 

  

 

736,246

 

Retained earnings

  

 

288,000

 

  

 

251,568

 

Accumulated other comprehensive income

                 

Net unrealized holding gains on fixed maturities and equity securities, net of tax expense of $85,850 in 2003 and $96,476 in 2002

  

 

159,435

 

  

 

179,170

 

Cumulative translation adjustments, net of tax benefit of $3,171 in 2003 and $4,239 in 2002

  

 

(5,889

)

  

 

(7,873

)


Total Shareholders’ Equity

  

 

1,177,997

 

  

 

1,159,111

 

Commitments and contingencies

                 

Total Liabilities and Shareholders’ Equity

  

$

7,504,808

 

  

$

7,408,560

 


 

See accompanying notes to consolidated financial statements.

 

 

3


Table of Contents

 

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Operations and Comprehensive Income

 

    

Three Months Ended

March 31,

 
 
    

2003

    

2002

 

    

(dollars in thousands,

except per share data)

 

OPERATING REVENUES

                 

Earned premiums

  

$

432,353

 

  

$

327,539

 

Net investment income

  

 

45,233

 

  

 

41,464

 

Net realized gains from investment sales

  

 

6,471

 

  

 

5,624

 


Total Operating Revenues

  

 

484,057

 

  

 

374,627

 


OPERATING EXPENSES

                 

Losses and loss adjustment expenses

  

 

280,019

 

  

 

234,456

 

Underwriting, acquisition and insurance expenses

  

 

135,636

 

  

 

101,249

 

Amortization of intangible assets

  

 

2,629

 

  

 

2,797

 


Total Operating Expenses

  

 

418,284

 

  

 

338,502

 


Operating Income

  

 

65,773

 

  

 

36,125

 

Interest expense

  

 

11,395

 

  

 

9,081

 


Income Before Income Taxes

  

 

54,378

 

  

 

27,044

 

Income tax expense

  

 

17,945

 

  

 

10,007

 


Net Income

  

$

36,433

 

  

$

17,037

 


OTHER COMPREHENSIVE LOSS

                 

Unrealized losses on securities, net of taxes

                 

Net holding losses arising during the period

  

$

(15,529

)

  

$

(8,579

)

Less reclassification adjustments for gains included in net income

  

 

(4,206

)

  

 

(3,655

)


Net unrealized losses

  

 

(19,735

)

  

 

(12,234

)

Currency translation adjustments, net of taxes

  

 

1,984

 

  

 

(498

)


Total Other Comprehensive Loss

  

 

(17,751

)

  

 

(12,732

)


Comprehensive Income

  

$

18,682

 

  

$

4,305

 


NET INCOME PER SHARE

                 

Basic

  

$

3.70

 

  

$

1.74

 

Diluted

  

$

3.70

 

  

$

1.73

 


 

See accompanying notes to consolidated financial statements.

 

 

4


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Changes in Shareholders’ Equity

 

    

Three Months Ended

March 31,

 
 
    

2003

    

2002

 

    

(dollars in thousands)

 

Common Stock

                 

Balance at beginning of period

  

$

736,246

 

  

$

735,569

 

Issuance of common stock and other equity transactions

  

 

205

 

  

 

268

 


Balance at end of period

  

$

736,451

 

  

$

735,837

 


Retained Earnings

                 

Balance at beginning of period

  

$

251,568

 

  

$

176,252

 

Net income

  

 

36,433

 

  

 

17,037

 

Repurchase of common stock

  

 

(1

)

  

 

(2

)


Balance at end of period

  

$

288,000

 

  

$

193,287

 


Accumulated Other Comprehensive Income

                 

Unrealized gains

                 

Balance at beginning of period

  

$

179,170

 

  

$

173,928

 

Net unrealized holding losses arising during the period, net of taxes

  

 

(19,735

)

  

 

(12,234

)


Balance at end of period

  

 

159,435

 

  

 

161,694

 

Cumulative translation adjustments

                 

Balance at beginning of period

  

 

(7,873

)

  

 

(641

)

Translation adjustments, net of taxes

  

 

1,984

 

  

 

(498

)


Balance at end of period

  

 

(5,889

)

  

 

(1,139

)


Balance at end of period

  

$

153,546

 

  

$

160,555

 


Shareholders’ Equity at End of Period

  

$

1,177,997

 

  

$

1,089,679

 


 

See accompanying notes to consolidated financial statements.

 

5


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Cash Flows

 

    

Three Months Ended

March 31,

 
 
    

2003

    

2002

 

    

(dollars in thousands)

 

OPERATING ACTIVITIES

                 

Net Income

  

$

36,433

 

  

$

17,037

 

Adjustments to reconcile net income to net cash provided by operating activities

  

 

67,172

 

  

 

33,822

 


Net Cash Provided By Operating Activities

  

 

103,605

 

  

 

50,859

 


INVESTING ACTIVITIES

                 

Proceeds from sales of fixed maturities and equity securities

  

 

880,426

 

  

 

417,568

 

Proceeds from maturities, calls and prepayments of fixed maturities

  

 

53,051

 

  

 

23,428

 

Cost of fixed maturities and equity securities purchased

  

 

(1,233,462

)

  

 

(460,001

)

Net change in short-term investments

  

 

(25,532

)

  

 

(84,613

)

Other

  

 

228

 

  

 

(4,334

)


Net Cash Used By Investing Activities

  

 

(325,289

)

  

 

(107,952

)


FINANCING ACTIVITIES

                 

Additions to long-term debt

  

 

198,020

 

  

 

 

Repayments and repurchases of long-term debt

  

 

(175,000

)

  

 

(37,423

)

Other

  

 

204

 

  

 

78

 


Net Cash Provided (Used) By Financing Activities

  

 

23,224

 

  

 

(37,345

)


Decrease in cash and cash equivalents

  

 

(198,460

)

  

 

(94,438

)

Cash and cash equivalents at beginning of period

  

 

444,236

 

  

 

296,781

 


Cash and Cash Equivalents at End of Period

  

$

245,776

 

  

$

202,343

 


 

See accompanying notes to consolidated financial statements.

 

6


Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—March 31, 2003

 

1. Principles of Consolidation

 

The consolidated balance sheet as of March 31, 2003, the related consolidated statements of operations and comprehensive income, changes in shareholders’ equity and cash flows for the three months ended March 31, 2003 and 2002, are unaudited. In the opinion of management, all adjustments necessary for fair presentation of such consolidated financial statements have been included. Such adjustments consist only of normal recurring items. Interim results are not necessarily indicative of results of operations for the full year. The consolidated balance sheet as of December 31, 2002 was derived from the Company’s audited annual consolidated financial statements.

 

The consolidated financial statements and notes are presented as permitted by Form 10-Q, and do not contain certain information included in the Company’s annual consolidated financial statements and notes. Readers are urged to review the Company’s 2002 annual report on Form 10-K for a more complete description of the Company’s business and accounting policies.

 

Certain reclassifications of prior year’s amounts have been made to conform with 2003 presentations.

 

2. Net Income per share

 

Net income per share was determined by dividing net income by the applicable shares outstanding (in thousands):

 

    

Three Months Ended March 31,

 
    

2003

  

2002


Net income, as reported (basic and diluted)

  

$

36,433

  

$

17,037


Average common shares outstanding

  

 

9,837

  

 

9,814

Dilutive potential common shares

  

 

19

  

 

38


Average diluted shares outstanding

  

 

9,856

  

 

9,852


 

3. Reinsurance

 

The table below summarizes the effect of reinsurance on premiums written and earned (dollars in thousands):

 

    

Three Months Ended March 31,

 

    

2003

    

2002

 

    

 

Written

 

  

 

Earned

 

  

 

Written

 

  

 

Earned

 

Direct

  

$

571,896

 

  

$

553,281

 

  

$

456,941

 

  

$

413,754

 

Assumed

  

 

72,840

 

  

 

35,320

 

  

 

61,705

 

  

 

14,257

 

Ceded

  

 

(169,773

)

  

 

(156,248

)

  

 

(144,530

)

  

 

(100,472

)


Net premiums

  

$

474,963

 

  

$

432,353

 

  

$

374,116

 

  

$

327,539

 


 

7


Table of Contents

3. Reinsurance (continued)

 

Incurred losses and loss adjustment expenses are net of reinsurance recoverables (ceded incurred losses and loss adjustment expenses) of $45.3 million and $97.4 million for the three months ended March 31, 2003 and 2002, respectively.

 

4. Company Obligated Mandatorily Redeemable Preferred Securities (8.71% Capital Securities)

 

On January 8, 1997, the Company arranged the sale of $150 million of 8.71% Capital Securities issued under an Amended and Restated Declaration of Trust dated January 13, 1997 (the Declaration) by Markel Capital Trust I (the Trust), a statutory business trust sponsored and wholly-owned by the Company. Proceeds from the sale of the 8.71% Capital Securities were used to purchase $154,640,000 aggregate principal amount of the Company’s 8.71% Junior Subordinated Deferrable Interest Debentures (the Debentures) due January 1, 2046, issued to the Trust under an indenture dated January 13, 1997 (the Indenture). The Debentures are the sole assets of the Trust. The Company has the right to defer interest payments on the Debentures for up to five years. The 8.71% Capital Securities and related Debentures are redeemable by the Company on or after January 1, 2007. Taken together, the Company’s obligations under the Debentures, the Indenture, the Declaration and a guarantee made by the Company provide, in the aggregate, a full, irrevocable and unconditional guarantee of payments of distributions and other amounts due on the 8.71% Capital Securities.

 

5. Convertible Notes Payable

 

During 2001, the Company issued $408.0 million principal amount at maturity, $112.9 million net proceeds, of Liquid Yield Option Notes (LYONs). The LYONs are zero coupon senior notes convertible into the Company’s common shares under certain conditions, with an initial conversion price of $243.53 per common share. The issue price of $283.19 per LYON represented a yield to maturity of 4.25%. The LYONs mature on June 5, 2031. The Company uses the effective yield method to recognize the accretion of discount from the issue price to the face amount of the LYONs at maturity. The accretion of discount is included in interest expense.

 

On June 5, 2004, if the price of the Company’s common stock is at or below specified thresholds based on a measurement period prior to that date, contingent additional principal will accrue on the LYONs at a rate of either 0.50% or 1.00% per year for a period of two years, depending on the price of the Company’s common shares. No contingent additional principal will accrue after June 5, 2006.

 

The Company will pay contingent cash interest to the holders of the LYONs during the six-month period commencing June 5, 2006 and during any six-month period thereafter if the average market price of a LYON for a specified period equals or exceeds 120% of the sum of the issue price, accrued original issue discount and contingent additional principal, if any, for the LYON.

 

Each LYON will be convertible into 1.1629 shares of common stock upon the occurrence of any of the following events: if the closing price of the Company’s common shares on the New York Stock Exchange exceeds specified levels, if the credit rating of the LYONs is reduced below specified levels, if the Company calls the LYONs for redemption, or if the Company is party to certain mergers or consolidations.

 

 

 

8


Table of Contents

5. Convertible Notes Payable (continued)

 

LYONs holders have the right to require the Company to repurchase the LYONs on June 5th of 2004, 2006, 2011, 2016, 2021 and 2026 at their accreted value on these dates as follows:

 

June 5, 2004

  

$

321.27

June 5, 2006

  

$

349.46

June 5, 2011

  

$

431.24

June 5, 2016

  

$

532.16

June 5, 2021

  

$

656.69

June 5, 2026

  

$

810.36

 

The Company may choose to pay the purchase price for such repurchases in cash or common shares of the Company. The Company may redeem the LYONs for cash on or after June 5, 2006 at their accreted value.

 

6. Unsecured Senior Notes

 

On February 25, 2003, the Company issued $200 million of 6.8% unsecured senior notes due February 15, 2013. The unsecured senior notes were issued under an existing shelf registration statement. Net proceeds to the Company were $198.0 million and were used to repay $175.0 million outstanding under the Company’s revolving credit facility. Remaining proceeds will be used to provide partial funding for $67.0 million of notes that mature on November 1, 2003.

 

7. Other Comprehensive Loss

 

Other comprehensive loss is composed of net holding losses on securities arising during the period less reclassification adjustments for gains included in net income. Other comprehensive loss also includes currency translation adjustments. The related tax benefit on net holding losses on securities arising during the period was $8.4 million and $4.6 million for the quarters ended March 31, 2003 and 2002, respectively. The related tax expense on the reclassification adjustments for gains included in net income was $2.3 million and $2.0 million for the quarters ended March 31, 2003 and 2002, respectively. The related tax expense (benefit) on currency translation adjustments was $1.1 million and $(0.3) million for the quarters ended March 31, 2003 and 2002, respectively.

 

8. Segment Reporting Disclosures

 

The Company operates in three distinct segments of the specialty insurance market: the Excess and Surplus Lines, Specialty Admitted and London Insurance Market segments.

 

All investing activities are included in the Investing operating segment. Discontinued programs and non-strategic insurance subsidiaries are included in Other for purposes of segment reporting.

 

The Company considers many factors, including the nature of the underwriting units’ insurance products, production sources, distribution strategies and regulatory environment in determining how to aggregate operating segments.

 

9


Table of Contents

8. Segment Reporting Disclosures (continued)

 

Segment profit or (loss) for each of the Company’s operating segments is measured by underwriting profit or (loss). The property and casualty insurance industry commonly defines underwriting profit or (loss) as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit or (loss) does not replace operating income (loss) or net income (loss) computed in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as a measure of profitability. Segment profit for the Investing operating segment is measured by net investment income, net of expenses, and net realized gains or losses.

 

The Company does not allocate assets to the Excess and Surplus Lines, Specialty Admitted and London Insurance Market operating segments for management reporting purposes. The total investment portfolio, cash and cash equivalents are allocated to the Investing operating segment. The Company does not allocate capital expenditures for long-lived assets to any of its operating segments for management reporting purposes.

 

a) Following is a summary of segment disclosures (dollars in thousands):

 

    

Three Months Ended

March 31,

 
    

2003

  

2002


Segment Revenues

             

Excess and Surplus Lines

  

$

236,674

  

$

157,128

Specialty Admitted

  

 

54,658

  

 

39,161

London Insurance Market

  

 

134,238

  

 

122,575

Investing

  

 

51,704

  

 

47,088

Other

  

 

6,783

  

 

8,675


Segment Revenues

  

$

484,057

  

$

374,627


    

Three Months Ended

March 31,

 
 
    

2003

    

2002

 

Segment Profit (Loss)

                 

Excess and Surplus Lines

  

$

27,803

 

  

$

7,298

 

Specialty Admitted

  

 

989

 

  

 

351

 

London Insurance Market

  

 

(3,756

)

  

 

(11,993

)

Investing

  

 

51,704

 

  

 

47,088

 

Other

  

 

(8,338

)

  

 

(3,822

)


Segment Profit

  

$

68,402

 

  

$

38,922

 


 

 

10


Table of Contents

8. Segment Reporting Disclosures (continued)

 

    

Three Months Ended

March 31,

 
 
    

2003

    

2002

 

U.S. GAAP Combined Ratios*

             

Excess and Surplus Lines

  

88

%

  

95

%

Specialty Admitted

  

98

%

  

99

%

London Insurance Market

  

103

%

  

110

%

Other

  

223

%

  

144

%

U.S. GAAP Combined Ratio

  

96

%

  

102

%


 

* The U.S. GAAP combined ratio measures the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums.

 

    

As of

 
    

March 31,

  

December 31,

    

2003

  

2002


Segment Assets

             

Investing

  

$

4,417,614

  

$

4,314,152

Other

  

 

3,087,194

  

 

3,094,408


Total Assets

  

$

7,504,808

  

$

7,408,560


 

b) The following summary reconciles significant segment items to the Company’s consolidated financial statements (dollars in thousands):

 

    

Three Months Ended

March 31,

 
 
    

2003

    

2002

 

Income before income taxes

                 

Segment profit

  

$

68,402

 

  

$

38,922

 

Unallocated amounts

                 

Amortization expense

  

 

(2,629

)

  

 

(2,797

)

Interest expense

  

 

(11,395

)

  

 

(9,081

)


Income Before Income Taxes

  

$

54,378

 

  

$

27,044

 


 

9. Derivative Financial Instruments

 

The Company held $36.0 million and $100.8 million of corporate bonds with embedded put options as of March 31, 2003 and December 31, 2002, respectively. These embedded derivatives are clearly and closely related to the host contracts and are not accounted for separately.

 

11


Table of Contents

10. Goodwill and Other Intangible Assets

 

The Company completed the transitional goodwill impairment test early in 2002 as required by Financial Accounting Standards Board Statement (Statement) No. 142, Goodwill and Other Intangible Assets. Goodwill is also required to be tested annually for impairment under Statement No. 142 and the Company has elected September 30 as its annual review date. The Company determined that there was no indication of goodwill impairment at either testing date in 2002.

 

Acquired Intangible Assets (dollars in thousands):

 

      

As of March 31, 2003

 
      

Gross

Carrying Amount

  

Accumulated Amortization

      

Net Carrying Amount


Amortized Intangible Assets

                          

Lloyd’s capacity costs

    

$

31,548

  

$

(30,050

)

    

$

1,498


Unamortized Intangible Assets

                          

Goodwill

    

$

405,548

  

$

(48,231

)

    

$

357,317


Intangible Assets

    

$

437,096

  

$

(78,281

)

    

$

358,815


 

      

As of December 31, 2002

 
      

Gross

Carrying Amount

  

Accumulated Amortization

      

Net Carrying Amount


Amortized Intangible Assets

                          

Lloyd’s capacity costs

    

$

31,548

  

$

(27,421

)

    

$

4,127


Unamortized Intangible Assets

                          

Goodwill

    

$

405,548

  

$

(48,231

)

    

$

357,317


Intangible Assets

    

$

437,096

  

$

(75,652

)

    

$

361,444


 

The amortization expense for intangible assets for the quarters ended March 31, 2003 and March 31, 2002 was $2.6 million and $2.8 million, respectively. Estimated annual amortization expense for acquired intangible assets will be approximately $4.1 million for 2003. Amortizable intangible assets will be fully amortized by June 30, 2003.

 

12


Table of Contents

10. Goodwill and Other Intangible Assets (continued)

 

There were no changes in the carrying amounts of goodwill for the quarter ended March 31, 2003. The following table shows the carrying amounts of goodwill by reporting unit at March 31, 2003 (dollars in thousands):

 

    

Excess and

Surplus Lines

    

London Insurance

Market

  

Total


Balance as of March 31, 2003

  

$

81,770

    

$

275,547

  

$

357,317


 

11. Contingencies

 

On January 31, 2001, the Company received notice of a lawsuit filed in the United States District Court of the Southern District of New York against Terra Nova Insurance Company Limited by Palladium Insurance Limited and Bank of America, N.A. seeking approximately $27 million plus exemplary damages in connection with alleged reinsurance agreements. This matter is still in the discovery phase and is not expected to be ready for trial before late 2003 or 2004. The Company believes it has numerous defenses to these claims, including the defense that the alleged reinsurance agreements and insurance policies were not valid. The Company intends to vigorously defend this matter; however, the outcome cannot be predicted at this time.

 

The Company has other contingencies that arise in the normal conduct of its operations. In the opinion of management, the resolutions of these contingencies are not expected to have a material impact on the Company’s financial condition or results of operations. However, adverse outcomes are possible and could negatively impact the Company’s financial condition or results of operations.

 

12. Stock Compensation Plans

 

The Company applies the intrinsic value recognition and measurement principles of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations, in accounting for stock based compensation plans. The Company has adopted the disclosure-only provisions of Statement No. 123, Accounting for Stock Based Compensation, as amended.

 

Stock based compensation cost, net of taxes, included in net income under APB Opinion No. 25 was $0.1 million in each of the quarters ended March 31, 2003 and 2002. Under the fair value method principles of Statement No. 123, pro forma stock based compensation cost, net of taxes, and pro forma net income would not have differed from reported amounts for the quarter ended March 31, 2003. Pro forma stock based compensation cost, net of taxes, and pro forma net income would have differed from reported amounts by less than $0.1 million for the quarter ended March 31, 2002. The pro forma impact of stock options issued after 1994 had no effect on basic or diluted net income per share in the periods presented.

 

13. Subsequent Event

 

On April 10, 2003, the Company issued an additional $50 million of 6.8% unsecured senior notes, due February 15, 2013 (see note 6). Net proceeds to the Company were $49.3 million and will primarily be used to repay a portion of the $67.0 million of notes that mature on November 1, 2003.

 

13


Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Critical Accounting Policies

 

The accompanying Consolidated Financial Statements and related notes have been prepared in accordance with U.S. GAAP and include the accounts of Markel Corporation and all subsidiaries (the Company).

 

Critical accounting policies are defined as those that are both important to the portrayal of the Company’s financial condition and results of operations and require management to exercise significant judgment. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of material contingent assets and liabilities, including litigation contingencies, at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are necessarily based on assumptions about numerous factors.

 

Management reviews its estimates and assumptions quarterly, including the adequacy of reserves for unpaid losses and loss adjustment expenses, reinsurance allowance for doubtful accounts, as well as, the recoverability of deferred tax assets and intangible assets and the evaluation of the investment portfolio for other than temporary declines in value. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.

 

Unpaid Losses and Loss Adjustment Expenses

 

The Company accrues liabilities for unpaid losses and loss adjustment expenses based upon estimates of the ultimate amounts payable. As of any balance sheet date, all claims have not yet been reported and some claims may not be reported for many years. As a result, the liability for unpaid losses and loss adjustment expenses includes significant estimates for incurred but not reported claims. Additionally, reported claims are in various stages of the settlement process. Each claim is settled individually based upon its merits and certain claims may take years to settle, especially if legal action is involved.

 

The Company uses a variety of techniques to establish the liabilities for unpaid losses and loss adjustment expenses, all of which involve significant judgments and assumptions. These techniques include detailed statistical analysis of past claim reporting, settlement activity, claim frequency and severity data, internal loss experience, the experience of clients and industry experience. More judgmental techniques are used in lines when statistical data is insufficient or unavailable. Estimates reflect implicit or explicit assumptions regarding the potential effects of external factors that include economic and social inflation, judicial decisions, law changes and recent trends in these factors. In some of the Company’s markets, and where the Company acts as a reinsurer, the timing and amount of information reported about underlying claims is in the control of third parties. This can also affect estimates and cause re-estimation as new information becomes available.

 

Reinsurance recoverables recorded with respect to insurance losses ceded to reinsurers under reinsurance contracts are also subject to estimation error. In addition to the factors cited above, estimates of reinsurance recoverables may prove uncollectible if the reinsurer is unable or unwilling to perform under the contract. The ceding of insurance does not legally discharge the ceding company from its primary liability for the full amount of the policies, and the ceding company is required to pay the loss and bear collection risk if the reinsurer fails to meet its obligation under the reinsurance agreement.

 

14


Table of Contents

 

The Company’s consolidated balance sheet at March 31, 2003 includes estimated unpaid losses and loss adjustment expenses of $4.4 billion and reinsurance recoverable on unpaid losses of $1.5 billion. Due to inherent uncertainties in estimating these amounts, the actual ultimate amounts may differ from the recorded amounts. Future effects from changes in these estimates will be recorded as a component of loss and loss adjustment expenses in the period of the change.

 

Investments

 

The Company completes a detailed analysis each quarter to assess whether the decline in the fair value of any investment below cost is deemed other than temporary. All securities with an unrealized loss are reviewed. Unless other factors cause the Company to reach a contrary conclusion, investments with a fair value of less than 80% of cost for more than 180 days are deemed to have a decline in value that is other than temporary. A decline in value that is considered to be other than temporary is charged to earnings based on the fair value of the security at the time of assessment, resulting in a new cost basis for the security.

 

Risks and uncertainties are inherent in the Company’s other than temporary decline in value assessment methodology. Risks and uncertainties could include but are not limited to: incorrect or overly optimistic assumptions about financial condition or liquidity, incorrect or overly optimistic assumptions about future prospects, inadequacy of any underlying collateral, unfavorable changes in economic or social conditions and unfavorable changes in interest rates or credit ratings. At March 31, 2003, the Company held securities with gross unrealized losses of approximately $24 million, or significantly less than 1% of the Company’s total investments, cash and cash equivalents. At March 31, 2003, all of these securities were reviewed and the Company believes there were no indications of impairment.

 

Deferred Income Taxes

 

The Company records deferred income taxes as assets or liabilities on its consolidated balance sheet to reflect the net tax effect of the temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and their respective tax bases. At March 31, 2003, a deferred tax asset of $96 million, net of a valuation allowance of $46 million, was recorded. In recording this deferred tax asset, management has made estimates and judgments that future taxable income will be sufficient to realize the value of the deferred tax asset.

 

Intangible Assets

 

The Company’s consolidated balance sheet as of March 31, 2003 includes goodwill of acquired businesses of approximately $357 million. This amount has been recorded as a result of prior business acquisitions accounted for under the purchase method of accounting. Under Financial Accounting Standards Board Statement (Statement) No. 142, Goodwill and Other Intangible Assets, goodwill is tested for impairment at least annually in lieu of amortization. The Company has elected September 30 as its annual review date.

 

A significant amount of judgment is required in performing goodwill impairment tests. Such tests include estimating the fair value of the Company’s reporting units. As required by Statement No. 142, the Company compares the estimated fair value of its reporting units with their respective carrying amounts including goodwill. Under Statement No. 142, fair value refers to the amount for which the entire reporting unit may be

 

15


Table of Contents

bought or sold. The Company’s methods for estimating reporting unit values include market quotations, asset and liability fair values and other valuation techniques, such as discounted cash flows and multiples of earnings or revenues. With the exception of market quotations, all of these methods involve significant estimates and assumptions.

 

Results of Operations

 

Three Months ended March 31, 2003 compared to Three Months ended March 31, 2002

 

The Company markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, the Company seeks to be a market leader. The financial goals of the Company are to earn consistent underwriting profits and superior investment returns to build shareholder value.

 

The Company competes in three segments of the specialty insurance marketplace: Excess & Surplus Lines, Specialty Admitted and the London Insurance Market. The Excess and Surplus Lines segment is comprised of five underwriting units, the Specialty Admitted segment consists of two underwriting units and the London Insurance Market segment is comprised of the ongoing operations of Markel International.

 

The Excess and Surplus Lines segment writes property and casualty insurance for non-standard and hard-to-place risks including catastrophe-exposed property, professional liability, products liability, general liability, commercial umbrella and other coverages tailored for unique exposures.

 

The Specialty Admitted segment writes risks that are unique and hard-to-place in the standard market but must remain with an admitted insurance company for marketing and regulatory reasons. The underwriting units in this segment write specialty program insurance for well-defined niche markets and personal and commercial property and liability coverages.

 

The Company participates in the London Insurance Market through Markel Capital Limited and Markel International Insurance Company Limited, two wholly-owned subsidiaries. Markel Capital Limited is the corporate capital provider for Markel Syndicate 3000 at Lloyd’s. Markel Syndicate Management Limited, a wholly-owned subsidiary, manages the Company’s Lloyd’s operations. The London Insurance Market segment writes specialty property, casualty, marine and aviation insurance and reinsurance.

 

Discontinued lines of business and non-strategic insurance subsidiaries are included in Other for segment reporting purposes. Other consisted primarily of discontinued Markel International programs and Corifrance, a wholly-owned subsidiary, for each of the quarters ended March 31, 2003 and 2002.

 

In late 1999, signs of a market hardening, that is stricter coverage terms and higher prices, began to emerge in the United States. Submissions and premium writings have increased substantially in the Excess and Surplus Lines and Specialty Admitted Markets since 2000. During 2001, premium rates also began to increase in the London Insurance Market. The terrorist attacks of September 11, 2001 continue to have a profound impact on the insurance market. During the last several quarters, demand for insurance products to manage risks accelerated while underwriting capacity decreased.

 

The Company anticipates that all segments of the specialty insurance marketplace in which it competes will continue to provide a favorable environment for its operations. For 2003 budgeting purposes, the Company anticipates gross premium growth of 15%, with domestic operations slightly higher and international operations slightly lower. Management continues to believe that this is a reasonable growth forecast for the full year. All of the Company’s insurance operations continue to achieve significant rate increases. The Company does not intend to relax underwriting standards in hard or soft insurance markets in order to obtain premium volume. Premium volume may vary significantly if the Company alters its product concentration to maintain or improve underwriting profitability.

 

 

16


Table of Contents

Following is a comparison of gross premium volume and earned premiums by significant underwriting segment:

 

 

Gross Premium Volume


       

Earned Premiums


Three Months Ended March 31,

       

Three Months Ended March 31,


2003

  

2002

  

(dollars in thousands)

  

2003

  

2002


$365,609

  

$

280,942

  

Excess and Surplus Lines

  

$

236,674

  

$

157,128

57,738

  

 

46,522

  

Specialty Admitted

  

 

54,658

  

 

39,161

199,690

  

 

170,959

  

London Insurance Market

  

 

134,238

  

 

122,575

21,699

  

 

20,223

  

Other

  

 

6,783

  

 

8,675


$644,736

  

$

518,646

  

Total

  

$

432,353

  

$

327,539


 

First quarter 2003 gross premium volume rose 24% to $644.7 million from $518.6 million in 2002.

 

Excess and Surplus Lines gross premium volume increased 30% to $365.6 million in the first quarter of 2003 from $280.9 million a year ago. The growth was due to increased submission activity and price increases in most programs. The most significant areas of growth in the first quarter of 2003 were in the Brokered Excess and Surplus Lines and the Essex Excess and Surplus Lines units. Gross premium volume for the Brokered Excess and Surplus Lines unit increased 48% to $97.2 million in the first quarter of 2003 from $65.8 million last year. Gross premium volume for the Essex Excess and Surplus Lines unit grew 27% to $132.0 million in the first quarter of 2003 from $104.3 million for 2002. The increase in gross premium volume at the Brokered Excess and Surplus Lines unit in the first quarter of 2003 was primarily due to growth in the casualty and excess and umbrella programs. The increase in gross premium volume at the Essex Excess and Surplus Lines unit for 2003 was primarily due to growth in the casualty programs.

 

For the first quarter of 2003, gross premium volume for the Specialty Admitted segment increased 24% to $57.7 million compared to $46.5 million in 2002. The increase was primarily due to higher submissions and price increases in most programs.

 

In the first quarter of 2003, gross premium volume for the London Insurance Market increased 17% to $199.7 million from $171.0 million in 2002. The increase was primarily the result of increased submissions and price increases in the professional indemnity and retail underwriting divisions. Writings in the London Insurance Market continued to meet the Company’s expectations both in terms of volume and price increases achieved.

 

Other gross written premiums consisted primarily of Corifrance’s writings in 2003 and 2002.

 

 

The Company purchases reinsurance in order to reduce its retention on individual risks and enable it to write policies with sufficient limits to meet policyholder needs. The Company’s underwriting philosophy seeks to offer products with limits that do not require significant amounts of reinsurance. The Company’s net retention of gross premium volume increased to 74% in the first quarter of 2003 compared to 72% in the prior year. The retention rate for the first quarter of 2003 increased primarily due to higher net retentions on most programs written by the London Insurance Market segment.

 

 

17


Table of Contents

Total operating revenues for the first quarter of 2003 increased to $484.1 million from $374.6 million in the prior year. The increase was primarily attributed to higher earned premiums resulting from increasing gross premium volume.

 

Earned premiums for the first quarter of 2003 increased 32% to $432.4 million from $327.5 million last year primarily as a result of increased gross written premiums in the Excess and Surplus Lines segment.

 

Excess and Surplus Lines earned premiums increased 51% to $236.7 million in first quarter 2003 from $157.1 million in 2002. The growth in 2003 was primarily due to higher gross premium volume over the past year in all Excess and Surplus Lines units.

 

Earned premiums for the Specialty Admitted segment grew 40% to $54.7 million from $39.2 million. The increase in 2003 was primarily due to growth in new programs and higher gross premium volume in existing lines of business over the past year.

 

London Insurance Market earned premiums rose 10% to $134.2 million for first quarter 2003 from $122.6 million in 2002. The growth in 2003 was primarily the result of increased gross premium volume over the past several quarters and higher retentions across most the underwriting divisions in the London Insurance Market.

 

Other earned premiums decreased in 2003 due to the run off of discontinued programs. Other earned premiums consists primarily of business written by Corifrance.

 

Net investment income for the first quarter of 2003 was $45.2 million compared to $41.5 million in the prior year. In 2003, a larger investment portfolio offset lower investment yields. During the first quarter of 2003, the Company added approximately $50 million on a cost basis to the equity investment portfolio. To the extent that the Company allocates additional funds to the equity portfolio in order to maximize long-term investment returns, current investment yields will decrease.

 

In the first quarter of 2003, the Company recognized $6.5 million of net realized gains compared to $5.6 million of net realized gains in 2002. Variability in the timing of realized and unrealized investment gains and losses is to be expected.

 

Net realized gains in 2003 were partially offset by $11.5 million of losses related to the write down of five equity securities to estimated fair value. These securities were deemed by management to have a decline in value that was other than temporary. Each of these securities had a fair market value of less than 80% of cost and had been in a continuous unrealized loss position for more than 180 days.

 

Total operating expenses for the first quarter of 2003 were $418.3 million compared to $338.5 million in 2002. The increase was primarily the result of both higher loss and loss adjustment expenses and higher underwriting, acquisition and insurance expenses as a result of higher premium volume compared to the same period of 2002.

 

18


Table of Contents

Following is a comparison of selected data from the Company’s operations (dollars in thousands):

 

    

Three Months Ended

March 31,


 
    

2003

    

2002

 

Gross premium volume

  

$

644,736

 

  

$

518,646

 

Net premiums written

  

$

474,963

 

  

$

374,116

 

Net retention

  

 

74

%

  

 

72

%

Earned premiums

  

$

432,353

 

  

$

327,539

 

Losses and loss adjustment expenses

  

$

280,019

 

  

$

234,456

 

Underwriting, acquisition and insurance expenses

  

$

135,636

 

  

$

101,249

 

Underwriting profit (loss)*

  

$

16,698

 

  

$

(8,166

)

U.S. GAAP Combined Ratios**

                 

Excess and Surplus Lines

  

 

88

%

  

 

95

%

Specialty Admitted

  

 

98

%

  

 

99

%

London Insurance Market

  

 

103

%

  

 

110

%

Other

  

 

223

%

  

 

144

%

Markel Corporation (Consolidated)

  

 

96

%

  

 

102

%


 

Following is a reconciliation of underwriting profit (loss) to operating income (dollars in thousands):

 

    

Three Months Ended

March 31,


 
    

2003

    

2002

 

Underwriting profit (loss)*

  

$

16,698

 

  

$

(8,166

)

Net investment income

  

 

45,233

 

  

 

41,464

 

Net realized gains from investment sales

  

 

6,471

 

  

 

5,624

 

Amortization of intangible assets

  

 

(2,629

)

  

 

(2,797

)


Operating Income

  

$

65,773

 

  

$

36,125

 


 

*   The property and casualty insurance industry commonly defines underwriting profit or (loss) as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit or (loss) does not replace operating income (loss) or net income (loss) computed in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as a measure of profitability. Underwriting profit (loss) provides a basis for management to evaluate the Company’s underwriting performance. An underwriting profit indicates a combined ratio of less than 100%, while an underwriting loss reflects a combined ratio greater than 100%.
**   The U.S. GAAP combined ratio measures the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums.

 

The Company reported a combined ratio of 96% in the first quarter of 2003 compared to a combined ratio of 102% in the first quarter of 2002.

 

The combined ratio for the Excess and Surplus Lines segment decreased to 88% in the first quarter 2003 from 95% in 2002. The improvement in 2003 primarily resulted from reduced loss ratios in all units as the impact of improved pricing, more restrictive coverage and better risk selection over the past several years began to emerge. In addition, the Excess and Surplus Lines segment expense ratio continued to benefit from lower commissions and additional premium volume.

 

19


Table of Contents

 

The combined ratio for Specialty Admitted decreased to 98% in the first quarter of 2003 from 99% in 2002. The segment benefited from an improved expense ratio due to higher premium volume in the first quarter of 2003. The Company continues to work to increase prices and reduce expenses in the Specialty Admitted segment in order to increase underwriting profits.

 

The London Insurance Market’s combined ratio decreased to 103% in the first quarter of 2003 from 110% in 2002. The segment’s combined ratio has steadily improved in each of the last five quarters. The improvement has resulted from a combination of lower loss ratios due to improved risk selection, pricing and the appropriate use of reinsurance and lower expense ratios due to lower commissions and expense control.

 

The underwriting loss from Other increased to $8.3 million in the first quarter of 2003 compared to $3.8 million in 2002. The increase was primarily due to an increase of $5.0 million in the allowance for potentially uncollectible reinsurance related to the Company’s discontinued operations. The Company’s action was the result of the weakened financial condition of certain reinsurance market participants.

 

Amortization of intangible assets was $2.6 million in the first quarter of 2003 compared to $2.8 million last year. Intangible assets, other than goodwill, will be fully amortized by the end of the second quarter of 2003.

 

Interest expense for the first quarter of 2003 was $11.4 million compared to $9.1 million in 2002. The increase for the three month period was primarily due to the issuance of $200 million of unsecured senior notes, at 6.8%, during the first quarter, partially offset by the use of proceeds from the issuance to repay $175 million outstanding under the Company’s revolving credit facility.

 

For the quarter ended March 31, 2003, the Company’s effective tax rate decreased to 33% from 37% in the first quarter of 2002. The decrease was primarily due to the elimination during 2002 of non-deductible interest expense as a result of the exchange of previously issued 7.0% and 7.2% senior notes of Markel International Limited, a wholly-owned subsidiary, for newly issued 7.0% and 7.2% senior notes of the Company. The Company also increased investment allocations to state and municipal securities, which are exempt from U.S. federal taxation.

 

Comprehensive income was $18.7 million for the first quarter of 2003 compared to $4.3 million in 2002. The improvement in 2003 was primarily due to higher net income, partially offset by a decrease in net unrealized investment gains compared to 2002. The Company reported net unrealized gains, net of taxes, on its fixed maturity and equity investments of $159.4 million at March 31, 2003 compared to $179.2 million at December 31, 2002.

 

Financial Condition as of March 31, 2003

 

The Company’s investments, cash and cash equivalents were $4.4 billion at March 31, 2003 compared to $4.3 billion at December 31, 2002.

 

For the three month period ended March 31, 2003, the Company reported net cash provided by operating activities of $103.6 million, compared to $50.9 million for the same period in 2002. The increase was primarily due to increased cash flows in the Excess and Surplus Lines segment due to growth in gross premium volume and continued underwriting profitability.

 

20


Table of Contents

 

For the three month period ended March 31, 2003, the Company reported net cash used by investing activities of $325.3 million compared to $108.0 million in 2002. The increased use of cash for investing activities during 2003 was primarily due to the allocation of increased operating cash flows to the Company’s investment portfolio.

 

For the three month period ended March 31, 2003, the Company reported net cash provided by financing activities of $23.2 million compared to net cash used by financing activities of $37.3 million in 2002. The net cash provided by financing activities during the three month period ended March 31, 2003 was primarily the result of the debt issuance during the first quarter of 2003 partially offset by the repayment of the outstanding balance under the Company’s revolving credit facility, as previously discussed. The net cash used by financing activities during the first quarter of 2002 was primarily due to the repayment of amounts outstanding under the Company’s revolving credit facility.

 

Subsequent to March 31, 2003, the Company issued an additional $50 million of the 6.8% unsecured senior notes, due February 15, 2013. Net proceeds to the Company were $49.3 million and will primarily be used to repay the $67.0 million of notes that mature on November 1, 2003.

 

Shareholders’ equity at March 31, 2003 was $1,178.0 million compared to $1,159.1 million at December 31, 2002. Book value per common share was $119.72 at March 31, 2003, compared to $117.89 at December 31, 2002.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign exchange rates and commodity prices. The Company’s consolidated balance sheets include assets and liabilities whose estimated fair values are subject to market risk. The primary market risks to the Company are equity price risk associated with investments in equity securities, interest rate risk associated with investments in fixed maturities and foreign exchange risk at Markel International. The Company has no material commodity risk.

 

The Company primarily manages foreign exchange risk by matching assets and liabilities in each foreign currency as closely as possible. Significant estimations and assumptions are required when establishing insurance balances such as reinsurance recoverables and reserves for unpaid losses and loss adjustment expenses. As a result, matching of assets and liabilities by currency is subject to change as actual results emerge.

 

The Company’s market risks at March 31, 2003 have not materially changed from those identified at December 31, 2002.

 

Item 4. Controls and Procedures

 

Within the ninety days prior to the date of this quarterly report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Chairman and Chief Executive Officer (CEO) and the Executive Vice President and Chief Financial Officer (CFO), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-14 (Disclosure Controls).

 

21


Table of Contents

 

The Company’s management, including the CEO and CFO, does not expect that its Disclosure Controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Based upon the Company’s controls evaluation, the CEO and CFO have concluded that, subject to the limitations noted above, the Company’s Disclosure Controls are effective to ensure that the information required to be disclosed by the Company in its periodic reports is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding disclosure and is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

 

There have been no significant changes in the Company’s internal controls or in other factors that could significantly affect those controls subsequent to the date the Company carried out this evaluation.

 

Safe Harbor and Cautionary Statement

 

This is a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995. It also contains general cautionary statements regarding the Company’s business, estimates and management assumptions. Future actual results may materially differ from those described in this report because of many factors. Among other things,

 

·   The impact of the events of September 11, 2001 will depend on the number of insureds and reinsureds affected by the events, the amount and timing of losses incurred and reported and questions of how coverage applies;
·   The occurrence of additional terrorist activities could have a material impact on the Company and the insurance industry;
·   The Company’s anticipated premium growth is based on current knowledge and assumes no man-made or natural catastrophes, no significant changes in products or personnel and no adverse changes in market conditions;
·   Recently enacted legislation requires the Company to offer terrorism insurance. The potential impact of this legislation on the Company is not believed to be material but cannot be determined at this time;
·   Changing legal and social trends and inherent uncertainties in the loss estimation process can adversely impact the adequacy of loss reserves and the allowance for reinsurance recoverables;
·   Industry and economic conditions can affect the ability and/or willingness of reinsurers to pay balances due;
·   The Company continues to closely monitor discontinued lines and reinsurance programs and exposures. Adverse experience in these areas could lead to additional charges;
·   Regulatory actions can impede the Company’s ability to charge adequate rates and efficiently allocate capital; and

 

22


Table of Contents
·   Economic conditions, interest rates and foreign exchange rate volatility can have a significant impact on the market value of fixed maturity and equity investments as well as the carrying value of other assets and liabilities.

 

The Company’s premium growth, underwriting and investment results have been and will continue to be potentially materially affected by these factors. Additional factors, which could affect the Company, are discussed in the Company’s reports on Forms 8-K, 10-Q and 10-K. By making these forward looking statements, the Company is not intending to become obligated to publicly update or revise any forward looking statements whether as a result of new information, future events or other changes. Readers are cautioned not to place undue reliance on any forward looking statements, which speak only as at their dates.

 

PART II. OTHER INFORMATION

 

Item 6. Exhibits and Reports on Form 8-K

 

(a) Exhibits.

 

The Exhibits to this Report are listed in the Exhibit Index.

 

(b)   On February 4, 2003, the Company filed a report on Form 8-K reporting under Item 5 and Item 7 announcing fourth quarter and year-end results.

 

(c)   On February 20, 2003, the Company filed a report on Form 8-K reporting under Item 5 and Item 7 related to the issuance of $200 million principal amount of 6.8% Senior Notes due 2013.

 

23


Table of Contents

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, this 7th day of May, 2003.

 

 

    

The Company

 

 

By:     /s/    ALAN I. KIRSHNER            


Alan I. Kirshner

Chairman and Chief Executive Officer

(Principal Executive Officer)

 

    

By:     /s/    ANTHONY F. MARKEL            


Anthony F. Markel

President

(Principal Operating Officer)

 

    

By:     /s/    STEVEN A. MARKEL             


Steven A. Markel

Vice Chairman

 

    

By:     /s/    DARRELL D. MARTIN            


Darrell D. Martin

Executive Vice President and

Chief Financial Officer

(Principal Financial Officer and

Principal Accounting Officer)

 

 

 

24


Table of Contents

 

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

 

I, Alan I. Kirshner, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Markel Corporation;

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

6. The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date: May 7, 2003

     

By:

 

  /s/     ALAN I. KIRSHNER


               

  Alan I. Kirshner

  Chairman and Chief Executive Officer

 

25


Table of Contents

 

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

 

I, Darrell D. Martin, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Markel Corporation;

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

6. The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date: May 7, 2003

     

By:

 

  /s/     DARRELL D. MARTIN


               

Darrell D. Martin

Executive Vice President and

Chief Financial Officer

 

26


Table of Contents

 

Exhibit Index

 

 

Number


  

Description


3(i)

  

Amended and Restated Articles of Incorporation, as amended (3.1)a

3(ii)

  

Bylaws, as amended (3.2)b

4(i)

  

Credit Agreement dated December 21, 1999, among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(i))c

4(ii)

  

First Amendment dated February 4, 2000, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(ii))c

4(iii)

  

Second Amendment and Consent dated March 17, 2000, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(iii))c

4(iv)

  

Third Amendment dated August 2, 2000, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(iv))c

4(v)

  

Fourth Amendment dated March 23, 2001, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(v))c

    

The registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of all instruments defining the rights of holders of convertible notes payable and long-term debt of the registrant and subsidiaries shown on the Consolidated Balance Sheet of the registrant at March 31, 2003 and the respective Notes thereto, included in the Quarterly Report on Form 10-Q.

10.1

  

Description of Executive Bonus Plan

99.1

  

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

99.2

  

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

a.   Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 10-Q for the quarter ended March 31, 2000.

 

b.   Incorporated by reference from Exhibit 4.2 to S-4 Registration Statement No. 333-88609, dated October 7, 1999

 

c.   Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 10-Q for the quarter ended September 30, 2002

 

 

27